IP Verse

Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection

Patent No. EP3494972 (titled "Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection") was filed by Viiv Healthcare on Jan 24, 2011. The application was issued on Dec 13, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFESep 13, 2024ELKINGTON AND FIFE
ZENTIVA KSSep 13, 2024REDDIE & GROSE
KILBURN & STRODESep 12, 2024KILBURN & STRODE
SANDOZSep 12, 2024TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSSep 12, 2024D YOUNG
BETAPHARM ARZNEIMITTELSep 11, 2024HAMM & WITTKOPP
HAMM & WITTKOPPSep 11, 2024HAMM & WITTKOPP
NEDERLANDSCH OCTROOIBUREAUSep 11, 2024NEDERLANDSCH OCTROOIBUREAU
STADA ARZNEIMITTELSep 11, 2024HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3494972

VIIV HEALTHCARE
Application Number
EP19151897A
Filing Date
Jan 24, 2011
Status
Granted And Under Opposition
Nov 10, 2023
Publication Date
Dec 13, 2023
External Links
Slate, Register , Google Patents